[HLFG] YoY Quarter Result on 31-Mar-2011 [#3]

Stock
[HLFG] HONG LEONG FINANCIAL GROUP BHD
Announcement Date
10-May-2011
Admission Sponsor
-
Sponsor
-
Financial Year
30-Jun-2011
Quarter
31-Mar-2011 [#3]
Profit Trend
QoQ- -66.38%
YoY- 86.43%
Quarter Report
Latest QR
Upcoming QR
HLFG's Result
HLFG's Financial Summary
View:
Show?
Quarter Result
31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 CAGR
Revenue 1,053,480 1,083,454 1,139,656 638,956 542,365 525,754 575,396 10.60%
PBT 727,859 618,536 857,563 388,887 255,035 271,813 283,882 16.98%
Tax -117,977 -139,734 -186,398 -32,394 -30,223 -65,140 -75,283 7.77%
NP 609,882 478,802 671,165 356,493 224,812 206,673 208,599 19.56%
-
NP to SH 414,680 320,036 513,266 264,589 141,923 131,994 133,344 20.80%
-
Tax Rate 16.21% 22.59% 21.74% 8.33% 11.85% 23.97% 26.52% -
Total Cost 443,598 604,652 468,491 282,463 317,553 319,081 366,797 3.21%
-
Net Worth 11,148,432 9,892,022 7,252,974 7,286,533 4,972,484 4,489,874 4,041,990 18.41%
Dividend
31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 CAGR
Div 260,477 238,987 155,420 186,039 145,030 - 145,844 10.14%
Div Payout % 62.81% 74.68% 30.28% 70.31% 102.19% - 109.38% -
Equity
31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 CAGR
Net Worth 11,148,432 9,892,022 7,252,974 7,286,533 4,972,484 4,489,874 4,041,990 18.41%
NOSH 1,041,909 1,039,077 1,036,139 1,033,550 1,035,934 1,039,322 1,041,749 0.00%
Ratio Analysis
31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 CAGR
NP Margin 57.89% 44.19% 58.89% 55.79% 41.45% 39.31% 36.25% -
ROE 3.72% 3.24% 7.08% 3.63% 2.85% 2.94% 3.30% -
Per Share
31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 CAGR
RPS 101.11 104.27 109.99 61.82 52.36 50.59 55.23 10.59%
EPS 39.80 30.80 49.50 25.60 13.70 12.70 12.80 20.80%
DPS 25.00 23.00 15.00 18.00 14.00 0.00 14.00 10.14%
NAPS 10.70 9.52 7.00 7.05 4.80 4.32 3.88 18.41%
Adjusted Per Share Value based on latest NOSH - 1,033,550
31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 CAGR
RPS 91.81 94.42 99.31 55.68 47.26 45.82 50.14 10.60%
EPS 36.14 27.89 44.73 23.06 12.37 11.50 11.62 20.80%
DPS 22.70 20.83 13.54 16.21 12.64 0.00 12.71 10.14%
NAPS 9.7153 8.6204 6.3206 6.3498 4.3333 3.9127 3.5224 18.41%
Price Multiplier on Financial Quarter End Date
31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 CAGR
Date 31/03/14 29/03/13 30/03/12 31/03/11 31/03/10 31/03/09 31/03/08 -
Price 15.68 14.94 12.30 9.00 8.45 4.68 4.44 -
P/RPS 15.51 14.33 11.18 14.56 16.14 9.25 8.04 11.56%
P/EPS 39.40 48.51 24.83 35.16 61.68 36.85 34.69 2.14%
EY 2.54 2.06 4.03 2.84 1.62 2.71 2.88 -2.07%
DY 1.59 1.54 1.22 2.00 1.66 0.00 3.15 -10.76%
P/NAPS 1.47 1.57 1.76 1.28 1.76 1.08 1.14 4.32%
Price Multiplier on Announcement Date
31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 CAGR
Date 21/05/14 09/05/13 16/05/12 10/05/11 24/05/10 06/05/09 29/04/08 -
Price 15.70 15.96 11.72 11.14 8.00 5.10 4.82 -
P/RPS 15.53 15.31 10.66 18.02 15.28 10.08 8.73 10.07%
P/EPS 39.45 51.82 23.66 43.52 58.39 40.16 37.66 0.77%
EY 2.54 1.93 4.23 2.30 1.71 2.49 2.66 -0.76%
DY 1.59 1.44 1.28 1.62 1.75 0.00 2.90 -9.52%
P/NAPS 1.47 1.68 1.67 1.58 1.67 1.18 1.24 2.87%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment